Anna C. Nilsson

1.0k citations
35 papers · 810 · h-index 14

Impact in

Papers in

    • Pneumonia and Respiratory Infections 8
    • Influenza Virus Research Studies 6
    • Respiratory viral infections research 4
    • Antimicrobial Resistance in Staphylococcus 7
    • COVID-19 Clinical Research Studies 2

Anna C. Nilsson

31 papers receiving 779 citations

Peers

Anna C. Nilsson
Comparison fields: 5 of 37
  • Microbiology 200
  • Applied Microbiology and Biotechnology 16
  • Epidemiology 241
  • Infectious Diseases 126
  • Clinical Biochemistry 4
Replace Mónica Fonseca-Aten with:
Mónica Fonseca-Aten United States
Matthew R. Blakiston New Zealand
Cynthia C. McCoig United States
Amy E. Ratliff United States
Robert Neil Whittaker Norway
Nadia Mahjoub France
Jannie J. van der Helm Netherlands
Samuel Bernal Spain
Fatou Secka United Kingdom
Mercedes Gurguí Spain
Anna C. Nilsson relative to Mónica Fonseca-Aten United States Mónica Fonseca-Aten's profile →
Citations per field
00.5×2×4×6×8×9×
Mónica Fonseca-Aten · 1×
Citations per year

Countries citing papers authored by Anna C. Nilsson

Since Specialization
Citations

This map shows the geographic impact of Anna C. Nilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna C. Nilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna C. Nilsson more than expected).

Fields of papers citing papers by Anna C. Nilsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna C. Nilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna C. Nilsson. The network helps show where Anna C. Nilsson may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna C. Nilsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna C. Nilsson Line = papers co-authored together Anna C. Nilsson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2008163
2 201492
3 201075
4 201251
5 201748
6 202142
7 201437
8 201135
9 202033
10 202028
11 201727
12 201827
13 201923
14 201418
15 201014
16 201613
17 202313
18 202313
19 20089
20 20159

About Anna C. Nilsson

Anna C. Nilsson is a scholar working on Epidemiology, Infectious Diseases, Microbiology, Neurology and Public Health, Environmental and Occupational Health, having authored 35 papers that have together received 810 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (8 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Influenza Virus Research Studies (6 papers), Respiratory viral infections research (4 papers), Microbial infections and disease research (3 papers), COVID-19 Clinical Research Studies (2 papers), Long-Term Effects of COVID-19 (2 papers) and Streptococcal Infections and Treatments (1 paper). The work is most often cited by research in Microbiology (200 citations), Applied Microbiology and Biotechnology (16 citations), Epidemiology (241 citations), Infectious Diseases (126 citations) and Clinical Biochemistry (4 citations). Anna C. Nilsson has collaborated with scholars based in Sweden, United States and Belgium. Frequent co-authors include Per Björkman, Kenneth Persson, Anders Widell, Christina Welinder‐Olsson, Håkan Janson, Disa Dahlman, Kristoffer Strålin, Christer Lidman, Eva Melander and Carl Spindler. Their work appears in journals such as Scandinavian Journal of Infectious Diseases, Scientific Reports, Antimicrobial Agents and Chemotherapy, BMC Infectious Diseases and International Journal of Antimicrobial Agents.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact